Autologous stem cell transplantation in hematological malignancies

Springer Semin Immunopathol. 2004 Nov;26(1-2):3-30. doi: 10.1007/s00281-004-0172-4. Epub 2004 Oct 7.

Author

Norbert-Claude Gorin¹

Affiliation

¹ Department of Hematology and Cell Therapy, and EBMT Paris office, Hôpital Saint-Antoine and Université Pierre et Marie Curie, 75012 Paris, France. norbert-claude.gorin@sat.ap-hop-paris.fr

PMID: 15480668
DOI: 10.1007/s00281-004-0172-4

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / therapeutic use
Bone Marrow Purging
Combined Modality Therapy
Disease-Free Survival
Hematologic Neoplasms / drug therapy
Hematologic Neoplasms / mortality
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia / therapy
Lymphoma, Non-Hodgkin / therapy
Prognosis
Transplantation, Autologous

Substances

Antineoplastic Agents